Core Viewpoint - The company, Meili Tianyuan Medical Health (02373), announces the completion of a significant share sale by CITIC Industrial Investment Fund Management Co., Ltd. (CPE), which has exited as a major shareholder, leading to a restructuring of the company's shareholder base and potential positive impacts on governance and market confidence [1]. Group 1 - CPE has completed the sale of most of its shares in the company as of August 18, 2025, and is no longer a major shareholder [1]. - The exit of CPE is expected to enhance the stability of the company's shareholder structure and introduce high-quality long-term investors, improving governance and boosting market confidence in the company's long-term value [1]. - The optimization of the shareholder structure is anticipated to increase the proportion of circulating shares, thereby enhancing market liquidity [1]. Group 2 - The company expresses gratitude to CPE for its strategic guidance during its development and successful market entry as an early investor [1]. - Following CPE's exit, Mr. Hu Tenghe and Mr. Geng Jiaqi have resigned from their positions as non-executive directors, effective August 18, 2025 [2]. - The board has appointed Mr. Gao Jianming and Ms. Yi Lin as non-executive directors, effective from August 18, 2025 [2].
美丽田园医疗健康(02373)：主要股东CPE完成出售股份